Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2012

01.07.2012 | Colorectal Cancer

Prognostic Factors for Locoregional Recurrences in Colon Cancer

verfasst von: M. A. G. Elferink, PhD, O. Visser, MD, PhD, T. Wiggers, MD, PhD, R. Otter, MD, PhD, R. A. E. M. Tollenaar, MD, PhD, J. A. Langendijk, MD, PhD, S. Siesling, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

There is increased interest in locoregional recurrences of rectal cancer. Despite comparable locoregional recurrence rates in colon cancer, only a few studies on locoregional recurrences among colon cancer patients have been published. This study was designed to identify prognostic factors for locoregional recurrences among patients with colon cancer in the Netherlands.

Methods

The study population was composed of patients who underwent radical surgical resections for invasive colon carcinoma, diagnosed in three regions of the Netherlands from 2000 to 2003. The Kaplan-Meier method was used to calculate 5-year locoregional recurrence rates (LRR). Conditional hazard rates were estimated by the life-table method. Multivariate Cox regression analyses were performed to identify prognostic factors and to calculate a Locoregional Recurrence Risk Score (LRRS).

Results

In total 127 of 2,282 patients developed locoregional recurrences within 5 years (LRR 6.4%). The risk of developing a locoregional recurrence was highest at 0.5–1 year after surgery. Patients with left-sided tumors, T3-T4 tumors, and positive lymph nodes and those who did not receive adjuvant chemotherapy were more likely to develop locoregional recurrences. Four risk groups based on the LRRS were defined. Five-year LRR was 2.5% for the very low-risk group and 25.1% for the high-risk group.

Conclusions

Although the locoregional recurrence rate in this study was relatively low, it remains a considerable problem. Identifying individual patients who might benefit from adjuvant chemotherapy may reduce the locoregional recurrence rate.
Literatur
3.
Zurück zum Zitat Gatta G, Faivre J, Capocaccia R, Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978–1989. EUROCARE Working Group. Eur J Cancer. 1998;34(14 Spec No):2176–83.PubMedCrossRef Gatta G, Faivre J, Capocaccia R, Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978–1989. EUROCARE Working Group. Eur J Cancer. 1998;34(14 Spec No):2176–83.PubMedCrossRef
4.
Zurück zum Zitat Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–9.PubMedCrossRef Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–9.PubMedCrossRef
5.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.PubMedCrossRef
6.
Zurück zum Zitat Lemmens VE, van Steenbergen LV, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010 April 29. Lemmens VE, van Steenbergen LV, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010 April 29.
7.
Zurück zum Zitat Thomson WH, Foy CJ, Longman RJ. The nature of local recurrence after colorectal cancer resection. Colorectal Dis. 2008;10(1):69–74.PubMed Thomson WH, Foy CJ, Longman RJ. The nature of local recurrence after colorectal cancer resection. Colorectal Dis. 2008;10(1):69–74.PubMed
8.
Zurück zum Zitat Hall NR, Finan PJ, Brown S, al-Jaberi T, Tsang CS. Comparison of prognosis in cancer of the colon and rectum. Colorectal Dis. 2000;2(3):159–64.CrossRef Hall NR, Finan PJ, Brown S, al-Jaberi T, Tsang CS. Comparison of prognosis in cancer of the colon and rectum. Colorectal Dis. 2000;2(3):159–64.CrossRef
9.
Zurück zum Zitat Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432–40.PubMedCrossRef Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432–40.PubMedCrossRef
10.
Zurück zum Zitat Dorrance HR, Docherty GM, O’Dwyer PJ. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum. 2000;43(4):492–8.PubMedCrossRef Dorrance HR, Docherty GM, O’Dwyer PJ. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum. 2000;43(4):492–8.PubMedCrossRef
11.
Zurück zum Zitat Harris GJ, Church JM, Senagore AJ et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34.PubMedCrossRef Harris GJ, Church JM, Senagore AJ et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34.PubMedCrossRef
12.
Zurück zum Zitat Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J: Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.PubMedCrossRef Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J: Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.PubMedCrossRef
13.
Zurück zum Zitat McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302(6791):1501–5.PubMedCrossRef McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302(6791):1501–5.PubMedCrossRef
14.
Zurück zum Zitat Visser O, Coebergh JWW, van Dijck JAAM, Siesling S. Incidence of cancer in the Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra; 2002. Visser O, Coebergh JWW, van Dijck JAAM, Siesling S. Incidence of cancer in the Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra; 2002.
15.
Zurück zum Zitat International Classification of Diseases for Oncology. 3rd edn. Geneva: WHO; 1976. International Classification of Diseases for Oncology. 3rd edn. Geneva: WHO; 1976.
16.
Zurück zum Zitat Hermanek P, Hutter R, Sobin L, Wagner G, Wittekind C, editors. TNM Atlas. 4th edn. Berlin: Springer-Verlag; 1997. Hermanek P, Hutter R, Sobin L, Wagner G, Wittekind C, editors. TNM Atlas. 4th edn. Berlin: Springer-Verlag; 1997.
18.
Zurück zum Zitat Snaebjornsson P, Jonasson L, Jonsson T, Moller PH, Theodors A, Jonasson JG. Colon cancer in Iceland–a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer. 2010;127(11):2645–53.PubMedCrossRef Snaebjornsson P, Jonasson L, Jonsson T, Moller PH, Theodors A, Jonasson JG. Colon cancer in Iceland–a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer. 2010;127(11):2645–53.PubMedCrossRef
19.
Zurück zum Zitat Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181(4):335–46.PubMed Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181(4):335–46.PubMed
20.
Zurück zum Zitat Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701.PubMedCrossRef Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701.PubMedCrossRef
21.
Zurück zum Zitat Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis. 2009;11(4):354–64.PubMedCrossRef Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis. 2009;11(4):354–64.PubMedCrossRef
22.
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433–41.PubMedCrossRef Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433–41.PubMedCrossRef
23.
Zurück zum Zitat Moertel CG, Fleming TR, MacDonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122(5):321–6.PubMed Moertel CG, Fleming TR, MacDonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122(5):321–6.PubMed
24.
Zurück zum Zitat Sargent D, Sobrero A, Grothey A et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7.PubMedCrossRef Sargent D, Sobrero A, Grothey A et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7.PubMedCrossRef
25.
Zurück zum Zitat Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200.
Metadaten
Titel
Prognostic Factors for Locoregional Recurrences in Colon Cancer
verfasst von
M. A. G. Elferink, PhD
O. Visser, MD, PhD
T. Wiggers, MD, PhD
R. Otter, MD, PhD
R. A. E. M. Tollenaar, MD, PhD
J. A. Langendijk, MD, PhD
S. Siesling, PhD
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-2183-4

Weitere Artikel der Ausgabe 7/2012

Annals of Surgical Oncology 7/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.